The Prospect of Repurposing Immunomodulatory Drugs for Adjunctive Chemotherapy against Tuberculosis: A Critical Review

Tuberculosis (TB) remains a global health emergency, with an estimated 2 billion people infected across the world, and 1.4 million people dying to this disease every year. Many aspects of the causative agent, Mycobacterium tuberculosis, make this disease difficult for healthcare and laboratory resea...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Chiyun, Bhakta, Sanjib
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832907/
https://www.ncbi.nlm.nih.gov/pubmed/33477812
http://dx.doi.org/10.3390/antibiotics10010091

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832907/
https://www.ncbi.nlm.nih.gov/pubmed/33477812
http://dx.doi.org/10.3390/antibiotics10010091

Ejemplares similares